Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases.
Business Model:
Revenue: $0
Employees: 51-200
Address: 830 Winter Street
City: Waltham
State: MA
Zip: 02451
Country: US
Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases.
Contact Phone:
+17817868230
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/16/2020
IPO Valuation:
$828M
Ticker Symbol:
DYN
IPO Price:
$19/share
Amount Raised:
$268M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2020 | Equity | - | 9/2020 | IPO | $268M |
|
4/2019 | Series A | 3 | $50M |
Atlas Venture MPM Capital Atlas Venture Forbion Capital Partners Atlas Venture MPM Capital Atlas Venture |
8/2020 | Series B | 8 | $115M |
Logos Capital Wellington Management Vida Ventures Franklin Templeton Investments Surveyor Capital Forbion Capital Partners Atlas Venture MPM Capital Surveyor Capital Vida Ventures Logos Capital Wellington Management Vida Ventures Franklin Templeton Investments Surveyor Capital Forbion Capital Partners Atlas Venture MPM Capital Surveyor Capital Vida Ventures |
1/2021 | Post-IPO Equity | $168M | 1/2018 | Seed Round | 1 | - |
RA Capital Management RA Capital Management |
3/2020 | Equity | - |
CureDuchenne Ventures CureDuchenne Ventures |
1/2018 | Seed Round | 1 | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|